Youth Protein TIMP2 Restores Cleanup Crews in the Aging Mouse Brain

Deep in the hippocampus, tiny immune cells called microglia spend their lives tidying up. They sweep away dead cell fragments, prune worn-out connections, and keep inflammation in check. As a mouse gets old, though, these cleaners get sloppy. A new study in mice finds that a single blood-borne protein, abundant in the young and scarce in the old, keeps microglia doing their job, and that topping it back up in elderly animals coaxes their sluggish cleaners back into shape. The protein is TIMP2, and it may sit closer to the heart of brain aging than anyone expected.

Aging is the biggest known risk factor for Alzheimer’s and other neurodegenerative diseases, yet why an old brain becomes vulnerable is still murky. Microglia are one obvious suspect, because when they falter, debris piles up and inflammation smoulders.

What the Cleaners Lose With Age

Researchers at the Icahn School of Medicine at Mount Sinai had already flagged TIMP2, short for tissue inhibitor of metalloproteinases 2, as a youth-associated factor: plentiful in young blood, then dwindling into adulthood and old age. Earlier work from the same lab tied it to memory and synaptic plasticity. What nobody had pinned down was whether it does anything for the brain’s immune cells. So the team went looking, using mice engineered to lack TIMP2 either everywhere in the body or only in specific cell types. About a fifth of microglia in the adult mouse hippocampus turned out to make the protein themselves.

Strip TIMP2 away and the microglia change character. They start looking activated, irritable, older than their years.

In animals lacking the protein, the cleaners clogged up with a lysosomal marker called CD68, struggled to engulf and clear cellular rubbish, and began showing molecular signatures of senescence, the biological equivalent of a work stoppage. Sluggish, senescent microglia are increasingly viewed as a driver of brain aging in their own right. The surrounding fluid in the hippocampus filled with inflammatory and stress-related proteins, measured directly in living, freely moving mice through a delicate sampling technique that draws off the brain’s interstitial fluid. It was, in effect, a portrait of a neighbourhood whose bin collection had quietly stopped.

“TIMP2 facilitates healthy function for the brain’s immune cells,” says Joseph Castellano, the neuroscientist who led the work. His team found that deleting the protein from microglia alone, or from neurons alone, reproduced much of the same mess, though more modestly than wiping it out altogether.

Topping Up the Tank

The real test was whether the damage could be undone. The team took 20-month-old mice, elderly by rodent standards, and gave them injections of TIMP2 straight into the bloodstream, using the same dosing schedule that had rescued memory in the lab’s earlier experiments. After a couple of weeks, in cohorts of nine mice per group, the aged microglia had shifted. Fewer of them carried the pro-inflammatory, senescent signature; more of them were once again hoovering up synaptic debris the way younger cells do. When the researchers stimulated cultured microglia with myelin, the fatty insulation that accumulates as brain wiring frays with age, the cells roughly doubled their output of TIMP2, hinting that the protein is part of how they normally rise to a mess. Single-cell readouts of gene activity told the same story, with whole populations of inflammatory cells thinning out after treatment.

There is a large caveat, and Castellano says so. This is mouse biology, not medicine. The study measured cells and molecules, not memory or behaviour, so it stops short of showing that fresher microglia make for a sharper animal, let alone a sharper person. And TIMP2 is a busy protein with many jobs, so exactly how it nudges the cleaners back to work is still not clear.

Still, the appeal of the idea is easy to see. If a factor that ebbs away with age is partly what lets the brain’s immune cells drift into dysfunction, then restoring it, rather than trying to block every downstream consequence, is a tantalisingly upstream place to intervene. Genetic risk for Alzheimer’s is heavily concentrated in genes that govern exactly the microglial jobs TIMP2 seems to prop up: clearing debris, handling lipids, keeping the lysosomal machinery humming. That overlap is why the researchers think the pathway is worth chasing.

“While additional studies are needed, this work provides new insight into how youth-associated factors influence pathways involved in brain aging,” he says.

For now, TIMP2 joins a small but growing list of young-blood factors that seem to talk to the aging brain. Whether any of that conversation can be usefully eavesdropped on in humans is the question that comes next.

Frequently Asked Questions